230 related articles for article (PubMed ID: 16308573)
21. Is nephrocalcin related to the urinary derivative (bikunin) of inter-alpha-trypsin inhibitor?
Tang Y; Grover PK; Moritz RL; Simpson RJ; Ryall RL
Br J Urol; 1995 Oct; 76(4):425-30. PubMed ID: 7551874
[TBL] [Abstract][Full Text] [Related]
22. Oxidized forms of uromodulin promote calcium oxalate crystallization and growth, but not aggregation.
Chaiyarit S; Thongboonkerd V
Int J Biol Macromol; 2022 Aug; 214():542-553. PubMed ID: 35752338
[TBL] [Abstract][Full Text] [Related]
23. The effect of Phyllanthus niruri on urinary inhibitors of calcium oxalate crystallization and other factors associated with renal stone formation.
Freitas AM; Schor N; Boim MA
BJU Int; 2002 Jun; 89(9):829-34. PubMed ID: 12010223
[TBL] [Abstract][Full Text] [Related]
24. Protein inhibitors of crystal growth.
Kaiser ET; Bock SC
J Urol; 1989 Mar; 141(3 Pt 2):750-2. PubMed ID: 2645434
[TBL] [Abstract][Full Text] [Related]
25. The modulatory effects of large and small extracellular vesicles from normal human urine on calcium oxalate crystallization, growth, aggregation, adhesion on renal cells, and invasion through extracellular matrix: An in vitro study.
Hadpech S; Chaiyarit S; Phuangkham S; Sukphan S; Thongboonkerd V
Biomed Pharmacother; 2024 Apr; 173():116393. PubMed ID: 38461684
[TBL] [Abstract][Full Text] [Related]
26. Urinary calcium oxalate crystal growth inhibitors.
Worcester EM
J Am Soc Nephrol; 1994 Nov; 5(5 Suppl 1):S46-53. PubMed ID: 7873744
[TBL] [Abstract][Full Text] [Related]
27. Calcium oxalate monohydrate binding protein: a diagnostic biomarker for calcium oxalate kidney stone formers.
Asokan D; Kalaiselvi P; Muhammed Farooq S; Varalakshmi P
Urol Res; 2004 Oct; 32(5):357-61. PubMed ID: 15365653
[TBL] [Abstract][Full Text] [Related]
28. Identification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in the urine of healthy and stone forming subjects.
Atmani F; Glenton PA; Khan SR
Urol Res; 1998; 26(3):201-7. PubMed ID: 9694603
[TBL] [Abstract][Full Text] [Related]
29. Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function.
Jaggi M; Nakagawa Y; Zipperle L; Hess B
Urol Res; 2007 Apr; 35(2):55-62. PubMed ID: 17345077
[TBL] [Abstract][Full Text] [Related]
30. Defective urinary crystallization inhibition and urinary stone formation.
Carvalho M; Lulich JP; Osborne CA; Nakagawa Y
Int Braz J Urol; 2006; 32(3):342-8; discussion 349. PubMed ID: 16813682
[TBL] [Abstract][Full Text] [Related]
31. Identification of structural domains in inter-alpha-trypsin involved in calcium oxalate crystallization.
Kobayashi H; Shibata K; Fujie M; Sugino D; Terao T
Kidney Int; 1998 Jun; 53(6):1727-35. PubMed ID: 9607205
[TBL] [Abstract][Full Text] [Related]
32. Citrate determines calcium oxalate crystallization kinetics and crystal morphology-studies in the presence of Tamm-Horsfall protein of a healthy subject and a severely recurrent calcium stone former.
Hess B; Jordi S; Zipperle L; Ettinger E; Giovanoli R
Nephrol Dial Transplant; 2000 Mar; 15(3):366-74. PubMed ID: 10692522
[TBL] [Abstract][Full Text] [Related]
33. Expression of proteins that inhibit calcium oxalate crystallization in vitro in the urine of normal and stone-forming individuals.
Hedgepeth RC; Yang L; Resnick MI; Marengo SR
Am J Kidney Dis; 2001 Jan; 37(1):104-112. PubMed ID: 11136174
[TBL] [Abstract][Full Text] [Related]
34. Uric acid-binding proteins in calcium oxalate stone formers and their effect on calcium oxalate crystallization.
Kalaiselvi P; Udayapriya KL; Selvam R
BJU Int; 1999 Jun; 83(9):919-23. PubMed ID: 10368229
[TBL] [Abstract][Full Text] [Related]
35. Elongation factor Tu on Escherichia coli isolated from urine of kidney stone patients promotes calcium oxalate crystal growth and aggregation.
Amimanan P; Tavichakorntrakool R; Fong-Ngern K; Sribenjalux P; Lulitanond A; Prasongwatana V; Wongkham C; Boonsiri P; Umka Welbat J; Thongboonkerd V
Sci Rep; 2017 Jun; 7(1):2953. PubMed ID: 28592876
[TBL] [Abstract][Full Text] [Related]
36. Selective protein enrichment in calcium oxalate stone matrix: a window to pathogenesis?
Wesson JA; Kolbach-Mandel AM; Hoffmann BR; Davis C; Mandel NS
Urolithiasis; 2019 Dec; 47(6):521-532. PubMed ID: 30993355
[TBL] [Abstract][Full Text] [Related]
37. The reappraisal of nephrocalcin--its role in the inhibition of calcium oxalate crystal growth and interaction with divalent metal ions.
Chang LC; Lin HS; Chen WC
Urol Res; 2001 Apr; 29(2):89-93. PubMed ID: 11396734
[TBL] [Abstract][Full Text] [Related]
38. Isolation and purification of a new glycoprotein from human urine inhibiting calcium oxalate crystallization.
Atmani F; Lacour B; Drüeke T; Daudon M
Urol Res; 1993 Jan; 21(1):61-6. PubMed ID: 8456540
[TBL] [Abstract][Full Text] [Related]
39. The effect of warfarin on urine calcium oxalate crystal growth inhibition and urinary excretion of calcium and nephrocalcin.
Worcester EM; Sebastian JL; Hiatt JG; Beshensky AM; Sadowski JA
Calcif Tissue Int; 1993 Oct; 53(4):242-8. PubMed ID: 8275352
[TBL] [Abstract][Full Text] [Related]
40. 2D map of proteins from human renal stone matrix and evaluation of their effect on oxalate induced renal tubular epithelial cell injury.
Aggarwal KP; Tandon S; Singh SK; Tandon C
Int Braz J Urol; 2013; 39(1):128-36. PubMed ID: 23489505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
